• L MEDOUAKH Département de Biologie, Faculté des sciences, Université d’Oran
  • A BENSOLTANE Département de Biologie, Faculté des sciences, Université d’Oran


Studies of gastric biopsies taken from ten hospitalised patients suffering from gastroduodenal diseases and were subjected to a oesogastroduodenal fibroscopy, with a fast urease test, histological, cytological examination and a microbiological culture make the evidence of H.pylori. ¶We had isolated H.pylori from seven patients among the ten patients having an infection with H.pylori announced by histology and urease test. H.pylori ¶identification was based on the morphological and biochemical characters. Our ¶research was reinforced by the realization of an antibiogram which can guide us towards an antibiotherapy for the eradication of H.pylori infection.

Bibliographies de l'auteur-e

L MEDOUAKH, Département de Biologie, Faculté des sciences, Université d’Oran
Laboratoire de microbiologie alimentaire et industrielle
A BENSOLTANE, Département de Biologie, Faculté des sciences, Université d’Oran
Laboratoire de microbiologie alimentaire et industrielle


- Myllyluoma E., Kajander k., Mikkola H., Kyronpalo S., Rasmussen M., Kankuri E., Sipponen P., Vapaatalo H. and Korpela R., “Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection”. Dig. Liv. Dis. 39 (2007), pp. 516–523.

- Carolyn J., Hildreth M.D., Cassio Lynm M.A., Richard M. and Glass M.D., “ Helicobacter pylori”.JAMA. 300 (11) (2008).

- Lee A., Fox J. and Hazell S., “Pathogenicity of Helicobacter pylori: a perspective”. Infect. Immun. 61 (1993), pp.1601-1610.

- Marshall, B.J., “Helicobacter pylori”. Gastoenterol. 89 (1994), pp. 116-27.

- de Korwin J.D., “Recommandations d’éradication de Helicobacter pylori en 2008“. Hépato. Gastro. 15 (5) (2008), pp. 363-70.

- Sobhani I., Vallot T. and Mignon M., “Helicobacter pylori, une bactérie Redécouverte . Son implication dans les maladies gastroduodénales “. Press. Med. 24 (1995), pp. 67-79.

- Megraud, F. and Wyatt J.L., “Maladie ulcéreuse et gastrite à l’heure d’H. pylori“. Conclusion et recommandation du jury. Gastroenterol. Clin. Biol. 20 (2000), pp. 155-162.

- Megraud F. and Lamouliatte H., “H.pylori and duodenal ulcer”. Evidence suggesting causation digdis. 38 (1997), pp. 632-644.

- Megraud F. and Lamouliatte H. “H. pylori and gastric ulcer” .Evidence suggesting causation digdis .37 (1999), pp.769-72.

- Brenner H., Bode G. and Boeing H., “Helicobacter pylori among offspring of patients with stomach cancer”. Gastroenterol.118 (2000), pp. 31-5.

- El Omar E. M., Oien K. Murray L. S. et al., “Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori”. Gastroenterol. 118 (2000), pp. 22-30.

- Uemura N., Okamoto S., Yamamoto S. et al., “Helicobacter pylori infection and the development of gastric cancer”. N. Engl. J. Med. 345 (2001), pp. 784-788.

- Colin R., “Heliobacter pylori en route vers l’an 2000. Quels sont les résultats de la conférence de consensus et pourquoi ? “. Actual. Innovat. Med. 2 (1996), pp. 1-5.

- Rechcinski T., Chmiela M., Malecka-Panas E., Planeta-Malecka I. and Rudnicka W.,“Serological indicators of Helicobacter pylori infection in adult dyspeptic patients and healthy blood donors”. Microbiol. Immunol. 41 (1997), pp. 337-393.

- Suganuma M., Kurusu M., Okabe S. et al., “Helicobacter pylori membrane protein 1: A new carcinogenic factor of Helicobacter pylori“. Cancer Res. 61 (2001), pp. 6356-9.

- Peek R.M. and Blaser M.J., “Helicobacter pylori and gastrointestinal tract Adenocarcinomas “. Nat Rev Cancer. 2 (2002), pp. 28-37.

- Fauchére J.L., “Infections gastriques à Helicobacter pylori“. Gastroenterolo. Clin. Biol. 18 (1994), pp. 212-216.

- Megraud F., "Méthode diagnostic directe et indirecte d’Helicobacter pylori“. Centre National de référence des Campylobacters et Helicobacters; Bordeaux (2004).

- Ricci C., Holton J. and Vaira D., “Diagnosis of Helicobacter pylori: Invasive and non-invasive tests. Best”. Pract. Res. Clin. Gastroenterol. 21(2) (2007), pp. 299- 313.

O]- Takahashi M., Taguchi H., Yamagushi H., Osaki T. and Kamiya S., “Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice”. J. Med. Microbiol. 49 (2OOO), pp. 635-642.

- Glupezynskiy N., Cantagrel A., Andersen L.P., Alarcon T., Lopez-Bren M. and Megraud F., “Comparaison of the E Test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori”. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002), pp. 549-552.

- Zhao W., Wu W. and Xu X., “Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice”. Vaccine. 25 (2007), pp. 7664–7673

- Lamouliatte H., Mégrand F. and Cayla R.., “Helicobacter pylori et pathologie Gastroduodénale“. Encyclopédie Médico-chirurgicale. Editions techniques. EMC. (1992).

- Megraud, F., “Méthodes diagnostiques pour Helicobacter pylori “. GEFH. (1992), pp. 15-19.

- Lozniewski A., “Méthodes diagnostiques de l’infection de Helicobacter pylori“. Gastroenterol. Clin. Biol. 20 (1996), pp. 111-118.

- Megraud F., “Helicobacter pylori. Diagnostic. Comment transporter les biopsies pour un examen bactériologique ?“. Gastrographie. 19 (1994), pp. 35 – 41.

- Delchier J.C., “Helicobacter pylori. Diagnostic. Que penser de l’uréase test (CLO- test) ? “. Gastrographie. 19 (1994), pp. 35 – 41.

- Megraud F., “Méthodes bactériologiques pour le diagnostic de Campylobacter pylori“. Gastroenterol. Clin. Biol. 13 (1989), pp. 31-36.

-Megraud F., “Comment rechercher Helicobacter pylori”. Gastroenterol. Clin. Biol. 20 (1996), pp. 38-43.

-Megraud F., Francis G.J. and Labigne., “Rapid urease test in the management of H. pylori associated gastritis”. Am. J. Gastrienterol. 82 (1998), pp. 200-210.

-Mégraud F., “ Méthodes diagnostiques directes et indirectes de Helicobacter pylori”. Gastroenterol. Clin. Biol. 18 (1994), pp. 217-222.

- Megraud F., “Mise en évidence de Helicobacter pylori au niveau de biopsies gastriques par les méthodes bactériologiques“. Revue française des laboratoires. (1994).

- Cellini L., Allocati N., Piatteli A., Petrelli L., Fanci P. and Dianelli B., “Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic Patients”. Microbiol. 18 (1995), pp. 187-192.

- Cellini L., Allocati N., Di Campli E., Masulli M., Di Bortoloneo S.and Dainelli B., “Helicobacter pylori isolated from stomach corpus and antrum: comparison of DNA patterns“. J. INFEC. 32 (1996), pp. 1-3.

- Minnis J.A., Taylor T.E., Knesek J.E., Peterson W.L. and Mcintire S. A., “Characterization of a 3,5-kbp plasmid from Helicobacter pylori”. Plasmid. 34 (1995), pp. 22-36.

- Riachi G. and colin R., “Helicobacter pylori. Méthodes de recherche“. Les dossiers du praticien. Impact. Med. 303 (1995), pp. 1-22.

- Franzin L., Pennazio M., Cabadi D., Paolo Rossini F. and Gioannini P., “Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy”. Curr. Microbiol. 40 (2000), pp. 96 – 100.

- Bruley Des Varannes S., “Helicobacter.pylori. Les méthodes diagnostiques“. Quot. Med. 321 (1996), pp. 14-48.

- Dorval E. D., “Gastrite chronique et ulcère duodénal: des maladies infectieuses? “Rev. Prat. Med. Gén. 162 (1992), pp. 82-83.

- Fagniez P. L., "Helicobacter bactérie de la décennie“. Rev. Prat. Med. 313 (1995), pp. 10-14.

- Megraud F., “Ulcère et gastrite : un nouveau domaine d’exploitation au laboratoire de biologie“. Feuillets de biologie. 15 (1989), pp. 25-28.

- Megraud F., "Helicobacter pylori. Historique et épidémiologie“. Quot. Med. (1996), pp. 4 –83.

-Bretagne J.F., “ Helicobacter pylori. De la bactérie à la pathologie ghastroduodénale “. Quot. Med. (1996), pp.9-13.

- Sobhani I., Flourié B., Lavergne A., Colimon R., Mignon M., Modigliani R. and Rambaud J.C., “Helicobacter pylori et pathologie gastroduodénale. Première partie : physiopathologie et méthodes de diagnostic“. Gastroenterol. Clin. Biol. 15 (1991), pp. 405-411.

- Souquet J.C., “Diagnostic de l’infection de Helicobacter pylori“. Hepato. Gastro. 2 (1995), pp. 17-22.

- Yousfi M.M., eddy R., Osato M.S. and Graham D., “Antre ou corps gastrique : quel est le meilleur site biopsique pour mettre en culture Helicobacter pylori“. Helicobacter. 1 (1997), pp. 25-26.

- Altman C.W., Lordouch A., Briantais M.J., Martin E., Jaques L.and Buffet C., “ Gastrite antrale au cours de l’alcoolisme chronique: rôle de la cirrhose et d’Helicobacter pylori“. Pres. Med. 24 (1995), pp. 708-710.

- Megraud F., “Méthodes de diagnostic de l’infection à Helicobacter pylori. Le point de vue du biologiste“. Lettre. Infec. 5 (1996), pp. 17-22.

- Megraud F., “Difficultés pratiques de l’éradication d’Helicobacter pylori dans la maladie ulcéreuse“. Quot. Med. (1994), pp. 9 – 13.

- Cayla R., “ Comment éradiquer Helicobacter pylori ?“ Gastroenterol. Clin. Biol. 20 (1996), pp. 119-130.

- Frasier B. A., Russel D.G., Flak P., Olsen A.N., Hammar M., Westbon T.U., Frazin L. et al., “Susceptibility of Helicobacter pylori to 20 antimicrobiol agence“. Bio future. 55 (2000), pp. 10-11.

- Tankovic J., Lamarque D., Lascols C., Soussy C.J. and Delchier J.C., “Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy”. Aliment. Pharmacol. Ther. 15 (2001), pp. 707-13.


Comment citer
MEDOUAKHL., & BENSOLTANEA. (2016). MICROBIOLOGICAL EVIDENCE OF Helicobacter pylori FROM PATIENTS SUFFERING FROM GASTRODUODENAL DISEASE. Sciences & Technologie. C, Biotechnologies, (44), 9-15. Consulté à l’adresse http://revue.umc.edu.dz/index.php/c/article/view/2868